Woodline Partners LP Has $1.11 Million Stock Position in Chemed Co. (NYSE:CHE)

Woodline Partners LP lessened its position in shares of Chemed Co. (NYSE:CHE - Free Report) by 94.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,092 shares of the company's stock after selling 35,513 shares during the quarter. Woodline Partners LP's holdings in Chemed were worth $1,108,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. UMB Bank n.a. lifted its stake in shares of Chemed by 300.0% during the fourth quarter. UMB Bank n.a. now owns 52 shares of the company's stock valued at $28,000 after acquiring an additional 39 shares during the period. Atala Financial Inc bought a new position in shares of Chemed during the fourth quarter worth about $29,000. CBIZ Investment Advisory Services LLC grew its holdings in shares of Chemed by 64.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock worth $30,000 after buying an additional 22 shares in the last quarter. Tortoise Investment Management LLC grew its holdings in shares of Chemed by 77.3% during the fourth quarter. Tortoise Investment Management LLC now owns 78 shares of the company's stock worth $41,000 after buying an additional 34 shares in the last quarter. Finally, Brown Brothers Harriman & Co. grew its stake in Chemed by 633.3% in the fourth quarter. Brown Brothers Harriman & Co. now owns 88 shares of the company's stock valued at $47,000 after purchasing an additional 76 shares in the last quarter. Institutional investors and hedge funds own 95.85% of the company's stock.

Analyst Ratings Changes

A number of research firms have weighed in on CHE. Wall Street Zen upgraded Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th. Royal Bank of Canada lifted their price target on Chemed from $667.00 to $674.00 and gave the stock an "outperform" rating in a report on Monday, April 28th.

Chemed Trading Up 0.5%

NYSE CHE traded up $3.07 during midday trading on Friday, hitting $576.26. The company had a trading volume of 32,596 shares, compared to its average volume of 102,948. The company has a market capitalization of $8.43 billion, a PE ratio of 29.11, a P/E/G ratio of 2.15 and a beta of 0.59. The firm has a 50-day moving average price of $581.34 and a 200-day moving average price of $565.81. Chemed Co. has a twelve month low of $512.12 and a twelve month high of $623.61.

Chemed (NYSE:CHE - Get Free Report) last announced its quarterly earnings data on Wednesday, April 23rd. The company reported $5.63 earnings per share for the quarter, beating the consensus estimate of $5.59 by $0.04. The firm had revenue of $646.94 million during the quarter, compared to analysts' expectations of $641.78 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The company's quarterly revenue was up 9.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $5.20 EPS. On average, equities analysts anticipate that Chemed Co. will post 21.43 EPS for the current year.

Chemed Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 17th. Shareholders of record on Thursday, May 29th will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 0.35%. The ex-dividend date is Thursday, May 29th. Chemed's payout ratio is presently 9.74%.

Insiders Place Their Bets

In other news, CEO Kevin J. Mcnamara sold 1,500 shares of the business's stock in a transaction dated Monday, May 5th. The stock was sold at an average price of $576.45, for a total value of $864,675.00. Following the transaction, the chief executive officer now directly owns 101,197 shares of the company's stock, valued at $58,335,010.65. The trade was a 1.46% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In the last three months, insiders have sold 7,500 shares of company stock valued at $4,401,120. 3.29% of the stock is currently owned by company insiders.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.